Baseline characteristics of the patients
| Variables | Entire cohort | Propensity score-matched cohort | ||||
| EVT (n=184) | No EVT (n=188) | P values | EVT (n=184) | No EVT (n=184) | P values | |
| Age, mean (SD) | 73 (10) | 74 (11) | 0.23 | 73 (10) | 74 (12) | 0.11 |
| Male, n (%) | 110 (60) | 109 (58) | 0.75 | 110 (60) | 103 (56) | 0.52 |
| NIHSS score, median (IQR) | 15 (9–19) | 10 (5–16) | <0. 0001 | 15 (9–19) | 12 (9–19) | 0.16 |
| ASPECTS, median (IQR) [min - max] | 8 (7–9) [3–10] | 8 (7–9) [0–10] | 0.59 | 8 (7–9) [3–10] | 7 (7–9) [4–10] | 0.92 |
| Use of IV tPA, n (%) | 93 (51) | 100 (53) | 0.67 | 93 (51) | 96 (52) | 0.83 |
| Process times (min), median (IQR) | ||||||
| Onset to door | 110 (50–258) | 150 (60–343) | 0.01 | 110 (50–258) | 120 (55–213) | 0.88 |
| Onset to puncture | 195 (128–386) | NA | 195 (128–386) | NA | ||
| Onset to reperfusion | 265 (180–470) | NA | 265 (180–470) | NA | ||
| Endovascular therapy | ||||||
| Using stent retrievers (%) | 102 (55) | NA | 102 (55) | NA | ||
ASPECTS, Alberta Stroke Programme Early CT Score; EVT, endovascular therapy; IQR, interquartile range; IV tPA, intravenous tissue plasminogen activator; NA, not applicable; NIHSS, National Institutes of Health Stroke Scale.